Assessment of the stem and progenitor cell content of cord blood units is a critical, time-sensitive step for cord blood banks and transplant centers
Vancouver, British Columbia (PRWEB) October 8, 2009
STEMCELL Technologies Inc., a Vancouver-based life sciences company, announces the launch of MethoCult® Express, an innovative methylcellulose-based medium specifically formulated to allow enumeration of total colony-forming cells after only 7 days of culture. With this new medium, reliable information on hematopoietic progenitor cell numbers in cord blood can be obtained much earlier than with standard 14-day assays.
"Assessment of the stem and progenitor cell content of cord blood units is a critical, time-sensitive step for cord blood banks and transplant centers," says Bert Wognum, Senior Scientist at STEMCELL Technologies. "Performing CFC-assays in MethoCult® Express allows faster, easier and more standardized assessment of progenitor numbers than 14-day assays. Obtaining accurate CFC-assay results in as early as 7 days may be very helpful for cord blood banks and transplant centers because the need to assess the progenitor cell content and quality of cord blood units during processing and cryopreservation may assist in selecting the most suitable graft for transplantation." With MethoCult® Express, cultures can also be maintained for a total of 14 - 16 days to permit identification of different colony types on the basis of morphological criteria similar to standard CFC-assays.
For more information about MethoCult® Express, visit http://www.stemcell.com/news_info/methocult_express.aspx.
About STEMCELL Technologies
STEMCELL Technologies Inc is a leader in the development and marketing of specialty cell culture media, cell separation products and ancillary reagents for life science research. Driven by science and enabled by close interactions with global leaders in cell biology and medicine, STEMCELL delivers over 900 products to research scientists in more than 70 countries worldwide. To learn more about how STEMCELL helps to make research work, visit http://www.stemcell.com.
Kenneth To, PhD, MBA, Product Manager - Hematology
STEMCELL Technologies Inc.